InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $49.96 million. The enterprise value is $12.23 million.
| Market Cap | 49.96M |
| Enterprise Value | 12.23M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 23.46 million shares outstanding. The number of shares has increased by 208.29% in one year.
| Shares Outstanding | 23.46M |
| Shares Change (YoY) | +208.29% |
| Shares Change (QoQ) | -28.59% |
| Owned by Insiders (%) | 20.14% |
| Owned by Institutions (%) | 44.08% |
| Float | 10.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.70 |
| PS Ratio | 8.09 |
| Forward PS | 6.90 |
| PB Ratio | 1.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.34, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.34 |
| Quick Ratio | 6.89 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.70% and return on invested capital (ROIC) is -52.15%.
| Return on Equity (ROE) | -55.70% |
| Return on Assets (ROA) | -46.50% |
| Return on Capital (ROIC) | -52.15% |
| Revenue Per Employee | $95,462 |
| Profits Per Employee | -$306,400 |
| Employee Count | 65 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.36 |
Taxes
In the past 12 months, InspireMD has paid $65,000 in taxes.
| Income Tax | 65,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +107.86% in the last 52 weeks. The beta is 0.89, so InspireMD's price volatility has been lower than the market average.
| Beta (1Y) | 0.89 |
| 52-Week Price Change | +107.86% |
| 50-Day Moving Average | 2.47 |
| 200-Day Moving Average | 2.88 |
| Relative Strength Index (RSI) | 37.40 |
| Average Volume (30 Days) | 37,096 |
Short Selling Information
The latest short interest is 88,909, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 88,909 |
| Short Previous Month | 90,783 |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, InspireMD had revenue of $6.21 million and -$19.92 million in losses. Loss per share was -$0.82.
| Revenue | 6.21M |
| Gross Profit | 1.81M |
| Operating Income | -21.14M |
| Pretax Income | -19.85M |
| Net Income | -19.92M |
| EBITDA | -19.62M |
| EBIT | -19.85M |
| Loss Per Share | -$0.82 |
Balance Sheet
The company has $39.02 million in cash and $1.04 million in debt, giving a net cash position of $37.99 million or $1.62 per share.
| Cash & Cash Equivalents | 39.02M |
| Total Debt | 1.04M |
| Net Cash | 37.99M |
| Net Cash Per Share | $1.62 |
| Equity / Book Value | 39.50M |
| Book Value Per Share | 1.68 |
| Working Capital | 38.14M |
Cash Flow
In the last 12 months, operating cash flow was -$16.38 million and capital expenditures -$369,000, giving a free cash flow of -$16.75 million.
| Operating Cash Flow | -16.38M |
| Capital Expenditures | -369,000 |
| Free Cash Flow | -16.75M |
| FCF Per Share | -$0.69 |
Margins
Gross margin is 29.12%, with operating and profit margins of -340.74% and -320.97%.
| Gross Margin | 29.12% |
| Operating Margin | -340.74% |
| Pretax Margin | -319.92% |
| Profit Margin | -320.97% |
| EBITDA Margin | -316.18% |
| EBIT Margin | -319.92% |
| FCF Margin | -269.86% |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -208.29% |
| Shareholder Yield | -208.29% |
| Earnings Yield | -39.66% |
| FCF Yield | -33.34% |
Analyst Forecast
The average price target for InspireMD is $4.63, which is 121.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.63 |
| Price Target Difference | 121.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 69.04% |
| EPS Growth Forecast (5Y) | -23.18% |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -3.09 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.09 |
| Piotroski F-Score | 4 |